Glenmark Pharmaceuticals recalls 1000mg Ranolazine Extended-Release Tablets due to CGMP deviations. This affects 60-count bottles with NDC 68462-320-60, lot 17240040, expiring Dec 2025.
CGMP Deviations
Glenmark Pharmaceuticals is recalling 1000mg Ranolazine Extended-Release Tablets 60-count bottles because of manufacturing deviations. This recall affects prescription-only medication that may have quality issues.
CGMP deviations refer to failures in the manufacturing process that could affect product quality. This means the medication might not be safe or effective as intended, but the exact risk isn't specified in the recall.
Prescription patients who have the 60-count bottle of Ranolazine 1000mg. Those with the specific NDC number and lot code are most at risk.
Check for the NDC number 68462-320-60 and lot number 17240040 on the bottle. The product is a prescription-only 1000mg Ranolazine Extended-Release Tablets 60-count bottle.
Look for NDC 68462-320-60 and lot 17240040 on the bottle label.
The recall states there were CGMP deviations, but does not specify if the product is unsafe. The manufacturer has not provided details on the exact risk.
Check for NDC 68462-320-60 and lot 17240040 on the bottle label. The product is a prescription-only 1000mg Ranolazine Extended-Release Tablets 60-count bottle.
The recall does not specify a remedy, so no action is required beyond checking the product details.
We’ve drafted a message you can send Glenmark to request your refund or repair — edit it as you like.
Subject: Recall D-0335-2025 — Glenmark Glenmark Hello, I own a Glenmark that is covered by recall D-0335-2025 from Glenmark. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
